Abstract
In developed countries the incidence of anal squamous cell carcinoma (SCC) has been rising; especially in women over the age of 60 years who present with more advanced disease stage than men. Historically, anal SCC screening has focused on people living with Human Immunodeficiency Virus (HIV) (PLWH) who are considered to be at the highest risk of anal SCC, and its precancerous lesion, anal squamous intraepithelial lesion (SIL). Despite this, women with vulval high-grade squamous epithelial lesions (HSIL) and SCCs have been shown to be as affected by anal HSIL and SCC as some PLWH. Nevertheless, there are no guidelines for the management of anal HSIL in this patient group. The ANCHOR trial demonstrated that treating anal HSIL significantly reduces the risk of anal SCC in PLWH, there is therefore an unmet requirement to clarify whether the screening and treatment of HSIL in women with a prior genital HSIL is also beneficial. This review presents the current evidence supporting the screening, treatment, and surveillance of anal HSIL in high-risk women with a previous history of genital HSIL and/or SCC.
Reference131 articles.
1. National Cancer Institute (2022, September 28). Surveillance Epidemiology and End Results Program. Cancer Stat Facts: Anal Cancer , Available online: https://seer.cancer.gov/statfacts/html/anus.html.
2. International trends in anal cancer incidence rates;Islami;Int. J. Epidemiol.,2017
3. Brogden, D.R., Kontovounisios, C., Mandalia, S., Tekkis, P., and Mills, S.C. (2021). The Role of Demographics, Social Deprivation and Ethnicity on Anal Squamous Cell Carcinoma Incidence in England. J. Clin. Med., 10.
4. A meta-analysis of anal cancer incidence by risk group: Toward a unified anal cancer risk scale;Clifford;Int. J. Cancer,2021
5. AIDS-related Kaposi sarcoma, Version 2.2019;Reid;J. Natl. Compr. Cancer Netw.,2019
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献